Fibe enters strategic partnership with Narayana Health

IMT News Desk
IMT News Desk
· 2 min read

Patients and caregivers can get up to ₹10 lacs medical expense loan in minutes at low-cost EMIs

Fibe (formerly known as EarlySalary) has entered into a strategic partnership with Narayana Health to offer low-cost and no-cost medical expense loans of up to Rs 10 lakhs for all elective and non-elective treatments on EMI under the CareNow PayLater proposition. Patients and caregivers under this proposition, can now seamlessly avail loan for healthcare emergencies within minutes with a repayment tenure of three months to two years. The scheme is also applicable to those with no lending history.

Amol Maheshwari, Chief Distribution Officer, Fibe said, “With this strategic partnership, Fibe’s Health arm & Narayana Health would enable millions of Indians to afford best-in-class healthcare services. At Fibe, it’s our mission to ensure that every Indian gets first-class healthcare treatment and shouldn’t live through the stress of finances. We anticipate that through this partnership with Narayana Health, we would take Affordable Healthcare to all consumer segments creating a great value proposition for society.”

Ashish Bajaj, Chief Marketing Officer, Narayana Health added, “Our partnership with Fibe will further boost this vision and help patients and caregivers have easy access to affordable healthcare financing. Every year we treat over 2.5+ million patients through our network of 21 hospitals and four heart centres across 13 cities in India and we are confident that this partnership will benefit all those who have trusted Narayana Health for their healthcare needs.”

Atul Bhatnagar, Group Head- Payor Relations, Narayana Health said “Our partnership with Fibe is just the beginning of bringing access to healthcare financing at a nominal cost. Narayana Health is known for its efforts in assisting patients when in need through various interventions and we will continue to work with external partners to further add on to the solutions in the coming future as well.”

To avail the loan, the patient or the caregiver availing the loan must be a resident of India, between 21-55 years of age with a minimum salary of Rs 15,000. The entire process takes just minutes to complete and requires basic documents like KYC details, PAN, and bank account statements.

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk